Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

282
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
282
Coronary Artery Disease IV: Medical Management01:26

Coronary Artery Disease IV: Medical Management

11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

110
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
110
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in pre-pregnancy diabetes and gestational diabetes by U.S. State, 2016-2024.

American journal of preventive cardiology·2026
Same author

Systematic examination of the PREVENT equations for cardiovascular disease risk.

American journal of preventive cardiology·2026
Same author

Trends in cardiovascular mortality among disaggregated Asian American subgroups: 2018-2022.

American journal of preventive cardiology·2026
Same author

Factors Influencing the Uptake of Digital Health Interventions for Cardiovascular Disease Prevention Among Healthcare Providers: A Systematic Review.

Global heart·2026
Same author

Racial and Ethnic Differences in Predicted Cardiovascular Disease Risk Using the PREVENT Equations in the US Population.

Circulation. Population health and outcomes·2026
Same author

Improving Primary Prevention in South Asians: A Regional Perspective for the 2026 Dyslipidemia Guidelines.

Journal of the American College of Cardiology·2026
Same journal

"The Real Cost" Campaign: Efficacy by Design.

American journal of preventive medicine·2026
Same journal

A Model for 21st Century Public Health Education: FDA's "The Real Cost" Youth Tobacco Prevention Campaigns.

American journal of preventive medicine·2026
Same journal

Fathers' adverse childhood experiences and children's behavior problems.

American journal of preventive medicine·2026
Same journal

Darknet cryptomarket listings for abortion medications after Dobbs.

American journal of preventive medicine·2026
Same journal

Modeling the Impact of Combined Individual and Population-level National strategies for preventing type 2 diabetes.

American journal of preventive medicine·2026
Same journal

Caregiving burden and health disparities: A nationwide study of 2,180 parents caring for children with developmental disabilities in South Korea.

American journal of preventive medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.8K

Cardiovascular Disease Mortality Trends, 2010-2022: An Update with Final Data.

Rebecca C Woodruff1, Xin Tong1, Fleetwood V Loustalot1

  • 1Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Chamblee, Georgia.

American Journal of Preventive Medicine
|September 25, 2024
PubMed
Summary
This summary is machine-generated.

Cardiovascular disease mortality rates declined in 2022 after pandemic increases, but remain elevated. Continued focus on cardiovascular disease prevention, detection, and management is crucial.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.3K

Related Experiment Videos

Last Updated: Jun 12, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.3K

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • Age-adjusted mortality rates (AAMR) for cardiovascular diseases (CVD) rose significantly in 2020 and 2021.
  • Provisional data suggested a continued increase in 2022, indicating substantial excess CVD deaths during the COVID-19 pandemic.

Purpose of the Study:

  • To provide updated estimates of CVD AAMR and excess deaths using final data for 2022.
  • To analyze trends in CVD mortality among U.S. adults aged 35 years and older from 2010 to 2022.

Main Methods:

  • Analysis of final Multiple Cause of Death files from the National Vital Statistics System (2010-2022).
  • Calculation of age-adjusted mortality rates (AAMR) for CVD as the underlying cause of death.
  • Estimation of excess CVD deaths from 2020 to 2022 for U.S. adults aged ≥35 years.

Main Results:

  • The CVD AAMR in 2022 was 434.6 deaths per 100,000, a decrease from 2021 (451.8) but similar to 2012 levels.
  • Provisional 2022 data overestimated the final AAMR by 4.6%.
  • An estimated 190,661 excess CVD deaths occurred between 2020 and 2022.

Conclusions:

  • The CVD AAMR among U.S. adults aged ≥35 years declined in 2022, reversing the adverse trend observed during the COVID-19 pandemic.
  • Despite the recent decline, 2022 CVD mortality rates remain higher than pre-pandemic levels.
  • There is an ongoing necessity for robust cardiovascular disease prevention, detection, and management strategies.